The Center will strongly encourage research and development of new immunological approaches for prevention, detection and treatment of human diseases, including cancer. The Center will be based primarily in Abilene and staffed initially with faculty from both departments of the School of Pharmacy. Research technologies at the Center will include but not limited to:
1) gene expression and protein engineering technologies,
2) hybridoma generation for monoclonal antibodies,
3) pre-clinical research for evaluation of experimental therapeutics (clinical pharmacology),
4) conjugation sciences,
5) microscopy and flow-cytometry, and
6) a Human Immunology Core (HIC) to provide high-thru-put analysis of blood and tissue specimens and to provide support for immune monitoring of patients participating in clinical trials focused on cancer treatment and immune interventions.
The HIC will establish collaboration with clinical investigators interested in the development of methodologies and monitoring devices. Center members will be encouraged to pursue commercialization of their research discoveries and inventions. Center members will collaborate with faculty and staff at the School of Pharmacy in Amarillo, Lubbock and Dallas and with clinical and basic science departments across the nation. The Center laboratory will provide pre-clinical support and testing of immunopharmaceuticals and will be GLP compliant. The Center will interface with biotech companies in Abilene and across the nation.